Acinetobacter Pneumonia Therapeutics Market Growth, Trends, Company Profiles, Market Share Analysis By Fact.MR
U.S. Acinetobacter Pneumonia Therapeutics Market Sees Pfizer Driving Innovation as Global Market Expands from USD 842.6 million in 2026 to USD 1,596.6 million by 2036 at a 6.6%. CAGR ROCKVILLE, MARYLAND , August 25, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound...
0 التعليقات 0 المشاركات 7 مشاهدة 0 معاينة